Upgrade to SI Premium - Free Trial

BioMarin Pharma (BMRN) Q2 Revenues Miss; Reaffirms FY Revs

August 1, 2019 4:59 PM
BioMarin Pharma (NASDAQ: BMRN) reported Q2 GAAP EPS of ($0.21), which may ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings Guidance

Next Articles